Cm. Kahler et al., INDUCTION OF ARACHIDONIC-ACID METABOLITE RELEASE BY HUMAN FIBROBLASTSIN PROLIFERATIVE VITREORETINOPATHY, European journal of pharmacology, 341(1), 1998, pp. 111-117
Proliferative vitreoretinopathy is a severe ocular disorder characteri
zed by unwanted proliferation of cells and excessive production of fib
rous tissue, which leads to the formation of cellular membranes on the
surface of the retina and in the vitreous. Proliferative vitreoretino
pathy is the most common cause of failure in retinal reattachment surg
ery, approximately occurring in one out of ten operated eves. Prolifer
ation of retinal pigment epithelial cells and fibroblasts is a corners
tone in the pathogenesis of proliferative vitreoretinopathy. An in vit
ro-proliferation assay showed previously that intraocular fluid from p
atients with proliferative vitreoretinopathy is potently effective in
stimulating proliferation of human fibroblasts. Here we show that expo
sure of human fibroblasts to vitreous fluids from patients with prolif
erative vitreoretinopathy causes a rapid and sustained increase in ara
chidonic acid metabolite release as measured by competitive enzyme-imm
unoassay. The findings implicate prostaglandin E-2 as a contributor to
enhanced intraocular fibrosis in proliferative vitreoretinopathy. As
prostaglandin E-2 is a mediator of continuous aqueous-blood retinal ba
rrier breakdown in this severe disease, cycclooxygenase inhibitors suc
h as acetylsalicylic acid, which was successfully used in this study f
or blocking the effect of intraocular fluid, may be useful agents in t
argeting the progression of intraocular fibrosis. (C) 1998 Elsevier Sc
ience B.V.